Manufacturing

How Can Stem Cells Rebuild the Human Intestine?
Biotech & Bioprocessing How Can Stem Cells Rebuild the Human Intestine?

Mapping the adult human intestine through spatial atlases is essential for bridging the biological gap between mouse models and human clinical applications. The human intestine remains one of the most biologically active environments in the body, defined by a relentless and necessary cycle of

LG Advances Industrial Efficiency With EXAONE Expert AI
Tech & Innovation LG Advances Industrial Efficiency With EXAONE Expert AI

Autonomous laboratories are reducing the cost of innovation by allowing researchers to explore broad scientific domains with a minimal number of physical experiments. This shift represents a fundamental transformation in how LG AI Research approaches machine intelligence, moving away from broad,

Can Morocco Bridge Its Growing Pharma Trade Deficit?
Management & Regulatory Can Morocco Bridge Its Growing Pharma Trade Deficit?

A strategic shift in customs policy has lowered barriers for essential drugs while simultaneously protecting local producers with higher tariffs on certain goods. This dual-track approach emerges as the nation grapples with a widening trade gap that is projected by BMI, a Fitch Solutions company,

How Can Data Drive Sustainable Oral Drug Delivery?
Management & Regulatory How Can Data Drive Sustainable Oral Drug Delivery?

Refining spray drying setups to enhance energy efficiency serves as a primary manufacturing lever for reducing the global warming potential of oral drug delivery components. This technical advancement reflects a broader trend where the pharmaceutical industry is navigating a pivotal transition to

Bora Biologics and Q Sera Partner to Scale RAPClot Production
Management & Regulatory Bora Biologics and Q Sera Partner to Scale RAPClot Production

Bora Biologics has executed over 200 cGMP batches to date, including more than 60 batches dedicated specifically to commercial supply programs. This extensive experience addresses a critical challenge in modern medicine: the need for reliable, high-speed diagnostic tools that can keep pace with an

Can the U.S. Solve the Talent Gap in Pharma Reshoring?
Management & Regulatory Can the U.S. Solve the Talent Gap in Pharma Reshoring?

Success in the reshoring initiative depends on treating human capital infrastructure with the same engineering precision as the commissioning of a multi-billion dollar plant. While news cycles are dominated by the sheer scale of the capital being deployed—roughly $500 billion across the domestic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later